Pfizer False Claims Act Ruling Keeps High Evidentiary Standards, Limits Employee Protections
Executive Summary
Appeals court rules that aggregate data of government expenditures are not a substitute evidence of actual false claims and that FCA does protect whistleblowers who just report regulatory violations.